Brazil to cancel Indian vaccine deal amid graft allegations, CNN Brasil reports
Brazil's Health Ministry will cancel a contract for Covaxin vaccines developed by India's Bharat Biotech that has faced accusations of irregularities, CNN Brasil reported on Tuesday. The Covaxin contract has become a headache for Brazilian President Jair Bolsonaro after whistleblowers went public with concerns over irregularities in the 1.6 billion reais ($324 million) deal.
- Country:
- Brazil
Brazil's Health Ministry will cancel a contract for Covaxin vaccines developed by India's Bharat Biotech that has faced accusations of irregularities, CNN Brasil reported on Tuesday. The Covaxin contract has become a headache for Brazilian President Jair Bolsonaro after whistleblowers went public with concerns over irregularities in the 1.6 billion reais ($324 million) deal. One Health Ministry official said he personally alerted the president about his concerns.
The Health Ministry did not respond to a request for comment. ($1 = 4.9403 reais)
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Google Fuels India's AI Future with $8 Million Investment
Indian Investors Go Global: A New Era of Diversified Portfolios
India-Jordan Relations Strengthened by Modi's Visit
Archna Vyas: Breaking Barriers as India's First Woman Country Director at Gates Foundation
Celebrating Minds: Proposal for National Researcher Day in India

